Journal List > J Korean Ophthalmol Soc > v.48(10) > 1007941

Kim, Wang, Park, and Lee: Risk Factors Leading to Enucleation or Evisceration in Endophthalmitis

Abstract

Purpose

To evaluate the risk factors associated with enucleation or evisceration in endophthalmitis patients.

Methods

The medical records of endophthalmitis cases from January 1995 to July 2006 were reviewed retrospectively. The cases were divided into 2 groups, the enucleation/evisceration group (36 eyes of 36 patients) who underwent enucleation or evisceration and the intraocular procedures group (61 eyes of 60 patients) who received intravitreal antibiotics injection and/or vitrectomy. We analyzed these cases with respect to age, sex, initial visual acuity, causes of endophthalmitis, systemic disease, and causative organisms.

Results

Older age (p=0.002), women (17/32, p=0.027), no light perception at presentation (33/37, p<0.001), endophthalmitis associated with corneal ulcer (25/25, p<0.001), and diabetes mellitus (14/20, p=0.001) were significantly associated with enucleation or evisceration.

Conclusions

Older age, poor initial visual acuity, endophthalmitis associated with corneal ulcer, and diabetes mellitus were strongly associated with enucleation or evisceration. If any of these factors are present, more intensive treatments are warranted to prevent loss of the eye.

References

1. Afran SI, Budenz DL, Albert DM. Does enucleation in the presence of endophthalmitis increase the risk of postoperative meningitis? Ophthalmology. 1987; 94:235–7.
crossref
2. Tsai YY, Tseng SH. Risk factors in endophthalmitis leading to evisceration or enucleation. Ophthalmic Surg Lasers. 2001; 32:208–12.
crossref
3. Kim JS, Lee PT, Park YG. A clinical study of evisceration and enucleation in Kwangju and Chonnam population. J Korean Ophthalmol Soc. 1993; 34:345–51.
4. Rim YS, Yoon PY. A statistical observation of enucleation. J Korean Ophthalmol Soc. 1977; 20:299–302.
5. Seo BR, Min WK, Ahn BH. Treatment of infectious endophthalmitis. J Korean Ophthalmol Soc. 1991; 32:561–8.
6. Park KS, Park YG, Min WK, Ahn BH. Microbiological diagnosis and visual outcome of infectious endophthalmitis. J Korean Ophthalmol Soc. 1994; 35:1715–22.
7. Chung SE, Ham DI. Visual prognosis of culture proven bacterial endophthalmitis. J Korean Ophthalmol Soc. 2006; 47:1292–7.
8. Yoo SJ, Cho SW, Kim JW. Clinical analysis of posttraumatic endophthalmitis. J Korean Ophthalmol Soc. 2004; 45:69–78.
9. Williams DF, Mieler WF, Abrams GW, Lewis H. Results and prognostic factors in penetrating ocular injuries with retained intraocular foreign bodies. Ophthalmology. 1988; 95:911–6.
crossref
10. Koc F, Sen E, Demirbay P, et al. Factors influencing treatment results in pseudophakic endophthalmitis. Eur J Ophthalmol. 2002; 12:34–9.
11. Punnonen E, Laatikainen L. Prognosis of perforating eye injuries with intraocular foreign bodies. Acta Ophthalmol. 1989; 67:483–91.
crossref
12. Bohigian GM, Olk RJ. Factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol. 1986; 101:332–4.
crossref
13. Thompson JT, Parver LM, Enger CL, et al. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. Ophthalmology. 1993; 100:1468–74.
crossref
14. The Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996; 122:830–46.
15. Brinton GS, Topping TM, Hyndiuk RA, et al. Posttraumatic endophthalmitis. Arch Ophthalmol. 1984; 102:547–50.
crossref
16. Somani S, Grinbaum A, Slomovic AR. Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome. Can J Ophthalmol. 1997; 32:303–10.
17. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis. Ophthalmology. 1982; 89:921–9.
crossref
18. Scott IU, Flynn HW, Feuer W, et al. Endophthalmitis associated with microbial keratitis. Ophthalmology. 1996; 103:1864–70.
crossref
19. Rowsey JJ, Newsom DL, Sexton DJ, Harms WK. Endophthalmitis: current approaches. Ophthalmology. 1982; 89:1055–66.
20. Scott IU, Flynn HW, Feuer W. Endophthalmitis after secondary intraocular lens implantation: a case-report study. Ophthalmology. 1995; 102:1926–31.
21. Kattan HM, Flynn HW Jr, Pflugfelder SC, et al. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology. 1991; 98:227–38.
22. Phillips WB, Tasman WS. Postoperative endophthalmitis in association with diabetes mellitus. Ophthalmology. 1994; 101:508–18.
crossref
23. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab. 1992; 18:187–201.
24. Morain WD, Colen LB. Wound healing in diabetes mellitus. Clin Plast Surg. 1990; 17:493–501.
crossref
25. Lee SY, Kang GM, Chang MH. Clinical observation on exogenous endophthalmitis. J Korean Ophthalmol Soc. 2002; 43:60–6.
26. Baum JL. Current concepts in ophthalmology. Ocular infection. N Engl J Med. 1987; 299:28.
27. Diamond JG. Intraocular management of endophthalmitis: systemic approach. Arch Ophthalmol. 1981; 99:96–9.

Table 1.
Characteristics of the study population
Enucleation/Evisceration group Intraocular procedures group Total p-value
Number of patients (eyes) 36 61 97
Age (years) 66.1± 12.6 54.6±19.1 0.002*
Sex
Male 19 (29.2%) 46 (70.8%) 65 0.027
Female 17 (53.1%) 15 (46.9%) 32

t-test.

Chi-square test.

Table 2.
Comparison of treatment modalities according to initial visual acuity
Visual acuity Enucleation/Evisceration group Intraocular procedures group Total p-value
NLP 33 (89.2%) 4 (10.8%) 37
LP, HM, FC 3 (5.5%) 52 (94.5%) 55 <0.001*
≥ 0.02 0 (0.0%) 5 (100.0%) 5

NLP=no light perception; LP=light perception; HM=hand motion; FC=finger counting.

Chi-square test.

Table 3.
Comparison of treatment modalities according to causes of endophthalmitis
Causes Enucleation/Evisceration group Intraocular procedures group Total p-value
Intraocular surgery 1 (2.8%) 35 (97.2%) 36 <0.001*
Corneal ulcer 25 (100.0%) 0 (0.0%) 25 <0.001*
Trauma 2 (9.1%) 20 (90.9%) 22 0.002*
Endogenous 3 (33.3%) 6 (66.7%) 9 0.80
Unknown 5 (100.0%) 0 (0.0%) 5 <0.001

Chi-square test,

Fisher's exact test. All statistical analyses are performed independently according to the causes of endophthalmitis.

Table 4.
Comparison of treatment modalities according to systemic diseases : diabetes mellitus, hypertension
Enucleation /Evisceration group Intraocular procedures group Total p-value
Diabetes mellitus (+) 14 (70.0%) 6 (30.0%) 20 0.001
       (-) 22 (28.6%) 55 (71.4%) 77
Hypertension (+) 9 (50.0%) 9 (50.0%) 18 0.212
      (-) 27 (34.2%) 52 (65.8%) 79

* Chi-square test.

Table 5.
Comparison of treatment modalities according to causative organisms
Organisms Enucleation/Evisceration group Intraocular procedures group Total
G (-) aerobes 6 8 14
   Pseudomonas aeruginosa 5 2 7
   Streptococcus - 4 4
   Branhamella catarrhalis 1 - 1
   Alcaligenes xylosoxidans - 2 2
G (-) anaerobes 4 4 8
   Serratia marcescens 1 - 1
   Klebsiella pneumoniae 3 2 5
   Enterobacter sakazakii - 2 2
G (+) anaerobes 6 8 14
   Arcanobacterium haemolyticum 0 1 1
   Staphylococcus epidermidis 3 3 6
   Staphylococcus aureus 1 1 2
   Staphylococcus hemolyticus 1 1 2
   Warneri - 1 1
   Enterococcus 1 1 2
Fungus Aspergillus 1 - 1
No growth 9 18 27
Total 26 38 64*

The cultivation of bacteria was conducted in 64 eyes out of 97.

TOOLS
Similar articles